MetaVia MTVA
NASDAQ MTVA
$1.46 +0.02 (+1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

MetaVia (MTVA) Profit After Tax (2015 - 2026)

MetaVia's (MTVA) quarterly Profit After Tax came in at -$1.9 million in Q4 2025, up 62.69% YoY from -$1.2 million in Q4 2024, and up 42.85% on a QoQ basis from -$3.4 million in Q3 2025.

MetaVia (MTVA) Profit After Tax (2015 - 2026) Analysis & Trends

MetaVia (MTVA) has 11 years of Profit After Tax data on file, last reported at -$1.9 million in Q4 2025.

  • Quarterly Profit After Tax rose 62.69% year-over-year to -$1.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$13.0 million (up 52.98% YoY) and the FY2025 annual result came in at -$13.0 million, up 52.98% from the prior year.
  • Profit After Tax rose to -$1.9 million in Q4 2025, from -$3.4 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$734000.0 in Q2 2023 to a low of -$10.1 million in Q2 2024.
  • A 5-year average of -$4.1 million and a median of -$3.7 million in 2023 frame the typical range for Profit After Tax.
  • Annual changes were most pronounced in 2021 — Profit After Tax slumped 26715.38% — and 2023, when it jumped 77.78%.
  • Tracing MTVA's Profit After Tax over 5 years: stood at -$4.6 million in 2021, then slipped by 2.36% to -$4.7 million in 2022, then retreated by 13.64% to -$5.3 million in 2023, then rose by 2.65% to -$5.2 million in 2024, then soared by 62.69% to -$1.9 million in 2025.
  • The last three Profit After Tax figures came in at -$1.9 million (Q4 2025), -$3.4 million (Q3 2025), and -$4.0 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.62 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 MetaVia 8.72 Mn -3.92 Mn - -5.32 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.32 Mn
Dec 31, 2025 -1.93 Mn
Sep 30, 2025 -3.38 Mn
Jun 30, 2025 -4.00 Mn
Mar 31, 2025 -3.67 Mn
Dec 31, 2024 -5.17 Mn
Sep 30, 2024 -5.65 Mn
Jun 30, 2024 -10.05 Mn
Mar 31, 2024 -6.71 Mn
Dec 31, 2023 -5.31 Mn
Sep 30, 2023 -3.82 Mn
Jun 30, 2023 -734,000.00
Mar 31, 2023 -2.60 Mn
Dec 31, 2022 -4.68 Mn
Sep 30, 2022 -3.10 Mn
Jun 30, 2022 -3.30 Mn
Mar 31, 2022 -2.88 Mn
Dec 31, 2021 -4.57 Mn
Sep 30, 2021 -3.46 Mn
Jun 30, 2021 -3.92 Mn